|
26 Companies |
|
24 Products |
|
24 Products |
|
22 Mechanisms of Action |
|
2 Trials |
|
625 News |
|
| «12345678910111213» |
- Enrollment change, Trial withdrawal: Recognize High Pressure Areas in Human Body to Prevent Decubitus Ulcers (clinicaltrials.gov) - Mar 29, 2016
P=N/A, N=0, Withdrawn, Sponsor: Assuta Medical Center
N=300 --> 0 | Not yet recruiting --> Withdrawn
- || Enrollment closed, Trial primary completion date, HEOR: Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix (clinicaltrials.gov) - Mar 25, 2016
P=N/A, N=224, Active, not recruiting, Sponsor: Integra LifeSciences Corporation
N=300 --> 0 | Not yet recruiting --> Withdrawn Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Sep 2016
- Enrollment closed, Trial primary completion date: LASER-1: Laser Therapy for Onychomycosis in Patients Wih Diabetes at Risk for Diabetic Foot Complications (clinicaltrials.gov) - Mar 21, 2016
P=N/A, N=64, Active, not recruiting, Sponsor: Medical Research Foundation, The Netherlands
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Sep 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2016 --> Mar 2017
- Enrollment change, Trial termination: Ischemic Foot Ulcers: Is Intervention Better Than Wound Care Alone (clinicaltrials.gov) - Mar 12, 2016
P=N/A, N=4, Terminated, Sponsor: University of Pittsburgh
Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2016 --> Mar 2017 N=100 --> 4 | Recruiting --> Terminated; slow enrollment
- || Epicyn / Sonoma Pharma, Amneal
Trial primary completion date: Pressure Ulcer Healing With Microcyn (clinicaltrials.gov) - Mar 9, 2016
P4, N=80, Recruiting, Sponsor: University of Alabama at Birmingham
N=100 --> 4 | Recruiting --> Terminated; slow enrollment Trial primary completion date: Feb 2016 --> Aug 2017
- Enrollment change, Trial withdrawal, Trial primary completion date: A Randomized Comparison of AmnioClear™ Human Allograft Amniotic Membrane vs. Moist Wound Dressing in the Treatment of Diabetic Wounds (clinicaltrials.gov) - Mar 5, 2016
P4, N=0, Withdrawn, Sponsor: Liventa Bioscience
Trial primary completion date: Feb 2016 --> Aug 2017 N=60 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jan 2015 --> Oct 2014
- || Trial primary completion date: Use of dHACM in the Treatment of Venous Leg Ulcers (clinicaltrials.gov) - Mar 3, 2016
P=N/A, N=120, Recruiting, Sponsor: MiMedx Group, Inc.
N=60 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jan 2015 --> Oct 2014 Trial primary completion date: Jul 2016 --> Dec 2016
- || Trial primary completion date: Trial of Dehydrated Human Amnion/Chorion Membrane (dHACM) In the Management of Diabetic Foot Ulcers (clinicaltrials.gov) - Mar 2, 2016
P=N/A, N=84, Recruiting, Sponsor: MiMedx Group, Inc.
Trial primary completion date: Jul 2016 --> Dec 2016 Trial primary completion date: Mar 2016 --> Dec 2016
- |||| Trial completion: Study Evaluating the Safety and Efficacy of Piperacillin/Tazobactam and Ampicillin/Sulbactam in Patients With Diabetic Foot Infections (clinicaltrials.gov) - Feb 27, 2016
P4, N=314, Completed, Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Trial primary completion date: Mar 2016 --> Dec 2016 No longer recruiting --> Completed
- Enrollment closed, Trial primary completion date: Safety Evaluation of the KLOX BioPhotonic System in Diabetic Foot Ulcers (clinicaltrials.gov) - Feb 23, 2016
P=N/A, N=10, Active, not recruiting, Sponsor: KLOX Technologies Inc.
No longer recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Mar 2016
- Trial completion: Safety Evaluation of the KLOX BioPhotonic System in Venous Leg Ulcers (clinicaltrials.gov) - Feb 23, 2016
P=N/A, N=10, Completed, Sponsor: KLOX Technologies Inc.
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Mar 2016 Active, not recruiting --> Completed
- Trial completion: Safety Evaluation of the KLOX BioPhotonic System in Stage II and III Pressure Ulcers (clinicaltrials.gov) - Feb 23, 2016
P=N/A, N=3, Completed, Sponsor: KLOX Technologies Inc.
Active, not recruiting --> Completed Recruiting --> Completed
- |||| Clinical data, Trial completion: Santyl Applications to Diabetic Foot Ulcers (clinicaltrials.gov) - Feb 18, 2016
P4, N=215, Completed, Sponsor: Healthpoint
Recruiting --> Completed Active, not recruiting --> Completed
- pirfenidone / Generic mfg.
Trial completion, Enrollment change: PirDFI: Effect of Topic Pirfenidone in Diabetic Ulcers (clinicaltrials.gov) - Feb 16, 2016
P3, N=36, Completed, Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Active, not recruiting --> Completed Recruiting --> Completed | N=50 --> 36
- || Trial primary completion date: Use of dHACM in the Treatment of Venous Leg Ulcers (clinicaltrials.gov) - Feb 6, 2016
P=N/A, N=120, Recruiting, Sponsor: MiMedx Group, Inc.
Recruiting --> Completed | N=50 --> 36 Trial primary completion date: Jan 2016 --> Jul 2016
- | Grafix (cryopreserved placental membrane) / Osiris
Trial completion, Enrollment change: GrafixCORE®: Open-Label Study to Evaluate the Safety and Efficacy of GrafixCORE® for Complex Diabetic Foot Wounds (clinicaltrials.gov) - Feb 2, 2016
P4, N=31, Completed, Sponsor: Osiris Therapeutics
Trial primary completion date: Jan 2016 --> Jul 2016 Recruiting --> Completed | N=40 --> 31
- |||| nitric oxide (EDX110) / Edixomed
Trial completion: ProNOx1: Nitric Oxide Generating Gel Dressing in Patients With Diabetic Foot Ulcers (clinicaltrials.gov) - Jan 21, 2016
P1/2, N=130, Completed, Sponsor: Edixomed Ltd
Recruiting --> Completed | N=40 --> 31 Active, not recruiting --> Completed
- |||| Locilex (pexiganan acetate) / PLx Pharma Inc
Trial primary completion date, Head-to-Head: OneStep-1: Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers (clinicaltrials.gov) - Jan 19, 2016
P3, N=180, Recruiting, Sponsor: Dipexium Pharmaceuticals, Inc.
Active, not recruiting --> Completed Trial primary completion date: Dec 2015 --> Mar 2016
- || Trial primary completion date: CMS: Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds (clinicaltrials.gov) - Jan 18, 2016
P=N/A, N=1500, Recruiting, Sponsor: Arteriocyte, Inc.
Trial primary completion date: Dec 2015 --> Mar 2016 Trial primary completion date: Oct 2015 --> Mar 2017
- |||| Locilex (pexiganan acetate) / PLx Pharma Inc
Trial primary completion date, Head-to-Head: OneStep-2: Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers (clinicaltrials.gov) - Jan 18, 2016
P3, N=180, Recruiting, Sponsor: Dipexium Pharmaceuticals, Inc.
Trial primary completion date: Oct 2015 --> Mar 2017 Trial primary completion date: Dec 2015 --> Mar 2016
- Trial primary completion date: SAS-FOOT: Impact of Sleep Apnea on Diabetic Foot Wound. (clinicaltrials.gov) - Jan 18, 2016
P=N/A, N=60, Recruiting, Sponsor: AGIR à Dom
Trial primary completion date: Dec 2015 --> Mar 2016 Trial primary completion date: Apr 2016 --> Apr 2017
- ||| Enrollment closed, Trial primary completion date: Efficacy and Safety Study of EscharEx to Treat (Debride) Hard to Heal Wounds (clinicaltrials.gov) - Jan 16, 2016
P2, N=72, Active, not recruiting, Sponsor: MediWound Ltd
Trial primary completion date: Apr 2016 --> Apr 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Mar 2016
- gevokizumab (S 78989) / Novartis
Trial completion: Proof of Concept Study of Gevokizumab in the Treatment of Pyoderma Gangrenosum (clinicaltrials.gov) - Dec 29, 2015
P2, N=8, Completed, Sponsor: XOMA (US) LLC
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Mar 2016 Active, not recruiting --> Completed
- |||| Trial completion: Efficacy Study of IZN-6D4 Gel for the Treatment of Diabetic Foot Ulcers (clinicaltrials.gov) - Dec 25, 2015
P2, N=82, Completed, Sponsor: Izun Pharma Ltd
Active, not recruiting --> Completed Recruiting --> Completed
- Enrollment change, Trial termination: Effect of an Oral Supplement Enriched in Amino Acids and the Leucine Metabolite B-hydroxy B-methylbutyrate (HMB) (clinicaltrials.gov) - Dec 15, 2015
P1, N=9, Terminated, Sponsor: Central Arkansas Veterans Healthcare System
Recruiting --> Completed N=76 --> 9 | Suspended --> Terminated; VA never granted approval following suspension of enrollment.
- |||| Trial primary completion date: ADHOC: The Sorbact® Antimicrobial Dressing in the Holistic Wound Management Of Diabetic Foot ulCers (Phase III Study) (clinicaltrials.gov) - Dec 10, 2015
P3, N=200, Recruiting, Sponsor: INRESA Pharma
N=76 --> 9 | Suspended --> Terminated; VA never granted approval following suspension of enrollment. Trial primary completion date: Jan 2016 --> Oct 2016
- Enrollment closed: Immune Response of Patients With Chronic, Staphylococcus Aureus-infected Wounds (clinicaltrials.gov) - Nov 30, 2015
P=N/A, N=76, Active, not recruiting, Sponsor: Centre Hospitalier Universitaire de Nīmes
Trial primary completion date: Jan 2016 --> Oct 2016 Recruiting --> Active, not recruiting
- Enrollment open, Trial primary completion date: The Pharmacokinetic Study of WH-1 Ointment in Subjects With Chronic Diabetic Foot Ulcers (clinicaltrials.gov) - Nov 24, 2015
P1, N=12, Recruiting, Sponsor: Oneness Biotech Co., Ltd.
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting | Trial primary completion date: Sep 2015 --> Mar 2016
- ||||| Enrollment closed: STRIDE 2: Phase 3 Study Evaluating Efficacy and Safety of DSC127 Compared With Vehicle and With Standard-of-care in Diabetic Foot Ulcers (clinicaltrials.gov) - Nov 21, 2015
P3, N=633, Active, not recruiting, Sponsor: Derma Sciences, Inc.
Not yet recruiting --> Recruiting | Trial primary completion date: Sep 2015 --> Mar 2016 Recruiting --> Active, not recruiting
- ||||| Enrollment closed: STRIDE 1: Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers (clinicaltrials.gov) - Nov 21, 2015
P3, N=422, Active, not recruiting, Sponsor: Derma Sciences, Inc.
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- plerixafor / Generic mfg.
Enrollment change, Trial withdrawal: Endogenous Progenitors Cell Therapy for Diabetic Foot Ulcers (clinicaltrials.gov) - Nov 17, 2015
P1, N=0, Withdrawn, Sponsor: New York University School of Medicine
Recruiting --> Active, not recruiting N=27 --> 0 | Not yet recruiting --> Withdrawn
- Trial termination: A RCT to Compare the Effects of Two Wound Products on Biofilm Disruption in DFUs (clinicaltrials.gov) - Nov 17, 2015
P=N/A, N=19, Terminated, Sponsor: Smith & Nephew Medical Ltd
N=27 --> 0 | Not yet recruiting --> Withdrawn Recruiting --> Terminated; Recruitment challenges
- ||||| Enrollment closed, Trial initiation date, Trial primary completion date: STRIDE 5: Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic Use (clinicaltrials.gov) - Nov 10, 2015
P3, N=200, Active, not recruiting, Sponsor: Derma Sciences, Inc.
Recruiting --> Terminated; Recruitment challenges Recruiting --> Active, not recruiting | Initiation date: Mar 2013 --> Jun 2013 | Trial primary completion date: Sep 2015 --> Jun 2016
- Trial completion, Enrollment change, Trial primary completion date: Dynamic Plantar Microvascular Skin Response to Compressive Loads in At-risk Diabetic and Healthy Control: a Pilot Study (clinicaltrials.gov) - Nov 10, 2015
P=N/A, N=18, Completed, Sponsor: Temple University
Recruiting --> Active, not recruiting | Initiation date: Mar 2013 --> Jun 2013 | Trial primary completion date: Sep 2015 --> Jun 2016 Recruiting --> Completed | N=50 --> 18 | Trial primary completion date: Oct 2016 --> Oct 2015
- cenplacel (PDA-002) / Celularity
Enrollment change: Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU (clinicaltrials.gov) - Oct 26, 2015
P1, N=15, Active, not recruiting, Sponsor: Celgene Corporation
Recruiting --> Completed | N=50 --> 18 | Trial primary completion date: Oct 2016 --> Oct 2015 N=24 --> 15
- || Trial primary completion date: Trial of Dehydrated Human Amnion/Chorion Membrane (dHACM) In the Management of Diabetic Foot Ulcers (clinicaltrials.gov) - Oct 23, 2015
P=N/A, N=84, Recruiting, Sponsor: MiMedx Group, Inc.
N=24 --> 15 Trial primary completion date: Jul 2015 --> Mar 2016
- Trial primary completion date: Shockwave Therapy of Chronic Diabetic Foot Ulcers (clinicaltrials.gov) - Oct 23, 2015
P=N/A, N=30, Recruiting, Sponsor: Odense University Hospital
Trial primary completion date: Jul 2015 --> Mar 2016 Trial primary completion date: Aug 2015 --> Dec 2015
- |||| Locilex (pexiganan acetate) / PLx Pharma Inc
Trial primary completion date, Head-to-Head: OneStep-2: Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers (clinicaltrials.gov) - Oct 23, 2015
P3, N=180, Recruiting, Sponsor: Dipexium Pharmaceuticals, Inc.
Trial primary completion date: Aug 2015 --> Dec 2015 Trial primary completion date: Sep 2015 --> Dec 2015
- |||| Locilex (pexiganan acetate) / PLx Pharma Inc
Trial primary completion date, Head-to-Head: OneStep-1: Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers (clinicaltrials.gov) - Oct 23, 2015
P3, N=180, Recruiting, Sponsor: Dipexium Pharmaceuticals, Inc.
Trial primary completion date: Sep 2015 --> Dec 2015 Trial primary completion date: Sep 2015 --> Dec 2015
- Trial completion, Enrollment change: Testing Fish Oil Derivatives In Healing Of Chronic Venous Leg Ulcers (clinicaltrials.gov) - Oct 17, 2015
P=N/A, N=41, Completed, Sponsor: Ohio State University
Trial primary completion date: Sep 2015 --> Dec 2015 Recruiting --> Completed | N=108 --> 41
- Trial primary completion date: Pilot Study on Auricular Vagus Nerve Stimulation Effects in Chronic Diabetic Wounds (clinicaltrials.gov) - Sep 25, 2015
P=N/A, N=20, Active, not recruiting, Sponsor: Medical University of Vienna
Recruiting --> Completed | N=108 --> 41 Trial primary completion date: May 2015 --> Dec 2015
- Trial completion, Trial primary completion date: Evaluation of Wound Dressings in the Reduction of Shear- Force (clinicaltrials.gov) - Sep 24, 2015
P=N/A, N=10, Completed, Sponsor: Maastricht University Medical Center
Trial primary completion date: May 2015 --> Dec 2015 Not yet recruiting --> Completed | Trial primary completion date: Nov 2015 --> Jun 2015
- Trial completion, Enrollment change, Trial primary completion date: Topical Sodium Nitrite for Chronic Leg Ulcers in Adult Patients With Blood Disorders (clinicaltrials.gov) - Sep 22, 2015
P1, N=28, Completed, Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting --> Completed | Trial primary completion date: Nov 2015 --> Jun 2015 Recruiting --> Completed | N=44 --> 28 | Trial primary completion date: Apr 2016 --> Sep 2015
- aspirin / Generic mfg.
Enrollment open, Trial initiation date: Aspirin for Venous Ulcers: Randomised Trial (AVURT) (clinicaltrials.gov) - Sep 18, 2015
P2, N=100, Recruiting, Sponsor: St George's, University of London
Recruiting --> Completed | N=44 --> 28 | Trial primary completion date: Apr 2016 --> Sep 2015 Not yet recruiting --> Recruiting | Initiation date: Jan 2015 --> Jun 2015
- ||| Enrollment closed, Trial primary completion date: DermACELL in Subjects With Chronic Wounds of the Lower Extremities (clinicaltrials.gov) - Sep 9, 2015
P4, N=202, Active, not recruiting, Sponsor: LifeNet Health
Not yet recruiting --> Recruiting | Initiation date: Jan 2015 --> Jun 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Dec 2015
- | Trial completion: Post Market Clinical Follow-up Investigation to Evaluate Performance and Safety on Pressure Ulcers, PU, When Using Exufiber as Intended (clinicaltrials.gov) - Sep 9, 2015
P=N/A, N=20, Completed, Sponsor: Molnlycke Health Care AB
Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Dec 2015 Active, not recruiting --> Completed
- | Trial completion: A Multicenter, Post Marketing Clinical Follow up (PMCF) Investigation to Evaluate the Performance and Safety of a Soft Silicone Foam Dressing and to Evaluate the Performance of Standard Care in Exuding Venous Leg Ulcers (clinicaltrials.gov) - Sep 9, 2015
P=N/A, N=30, Completed, Sponsor: Molnlycke Health Care AB
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: MxT Ag 05: TITLE: An Open, Non-comparative, Multi-centre Post Marketing Clinical Follow-up (PMCF) Investigation to Evaluate Performance and Safety on Diabetic Foot Ulcer, DFU, When Using Mepilex Transfer Ag as Intended (clinicaltrials.gov) - Sep 9, 2015
P4, N=30, Completed, Sponsor: Molnlycke Health Care AB
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Enrollment open, Trial initiation date, Trial primary completion date: DFUPS: Diabetic Foot Ulcer Prevention System (clinicaltrials.gov) - Sep 3, 2015
P1, N=100, Recruiting, Sponsor: King's College Hospital NHS Trust
Active, not recruiting --> Completed Not yet recruiting --> Recruiting | Initiation date: Dec 2014 --> Jul 2015 | Trial primary completion date: Oct 2015 --> Apr 2016
- ||| Clinical data, Enrollment closed: Santyl Applications to Diabetic Foot Ulcers (clinicaltrials.gov) - Aug 29, 2015
P4, N=200, Active, not recruiting, Sponsor: Healthpoint
Not yet recruiting --> Recruiting | Initiation date: Dec 2014 --> Jul 2015 | Trial primary completion date: Oct 2015 --> Apr 2016 Recruiting --> Active, not recruiting